Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028976 · ClinicalTrials.gov registry record · Phase 3
Obesity, Inflammation and Oxidative Stress
A Phase 3 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 3
- Development phase
- 512
- Enrollment target
NCT01028976 is a Phase 3 study that has completed, run by University of California, Berkeley. The registered enrollment target is 512 participants.
The verdict
NCT01028976, a Phase 3 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 512 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.
Interventions
- DIETARY_SUPPLEMENT Vitamin C (ascorbic acid)
- DIETARY_SUPPLEMENT Placebo tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028976
The ClinicalTrials.gov registry entry for NCT01028976 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin C (ascorbic acid) is the first listed.
NCT01028976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028976 about?
NCT01028976 is a clinical study titled "Obesity, Inflammation and Oxidative Stress". The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.
What is the current status of trial NCT01028976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 512 participants. The study started on 2010-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01028976?
The interventions under investigation include: Vitamin C (ascorbic acid) (DIETARY_SUPPLEMENT), Placebo tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01028976?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.